It has been shown that miR-21 modulates cell growth, invasion, and apoptosis by targeting RECK in many cancers, such as oral cancer [51], esophageal cancer [52], prostate cancer [53], and glioma [54], however the relationship between miR-21 and RECK in lung cancer is largely unknown. This evidence concerns the gene RECK and central nervous system cancer.